{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:15:25Z","timestamp":1789744525686,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470302"],"award-info":[{"award-number":["81470302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81421002"],"award-info":[{"award-number":["81421002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730006"],"award-info":[{"award-number":["81730006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400134"],"award-info":[{"award-number":["81400134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400152"],"award-info":[{"award-number":["81400152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Municipal Science and Technology Commission Grant","award":["15JCZDJC35800"],"award-info":[{"award-number":["15JCZDJC35800"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-1-018"],"award-info":[{"award-number":["2016-I2M-1-018"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-1-017"],"award-info":[{"award-number":["2016-I2M-1-017"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016GH3100001"],"award-info":[{"award-number":["2016GH3100001"]}]},{"name":"Novo Nordisk Hemophilia Research Fund"},{"name":"the Ministry of Science and Technology of China","award":["2016YFA0100600"],"award-info":[{"award-number":["2016YFA0100600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-0839-8","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T10:03:52Z","timestamp":1524132232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system"],"prefix":"10.1186","volume":"9","author":[{"given":"Cuicui","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"issue":"5","key":"839_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.ymthe.2017.03.033","volume":"25","author":"AW Nienhuis","year":"2017","unstructured":"Nienhuis AW, Nathwani AC, Davidoff AM. Gene therapy for hemophilia. Mol Ther. 2017;25(5):1163\u20137.","journal-title":"Mol Ther"},{"issue":"21","key":"839_CR2","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","volume":"371","author":"AC Nathwani","year":"2014","unstructured":"Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med. 2014;371(21):1994\u20132004.","journal-title":"N Engl J Med"},{"issue":"6121","key":"839_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823\u20136.","journal-title":"Science"},{"issue":"6121","key":"839_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339(6121):819\u201323.","journal-title":"Science"},{"issue":"2","key":"839_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jmedgenet-2015-103409","volume":"53","author":"HY Xue","year":"2016","unstructured":"Xue HY, Ji LJ, Gao AM, Liu P, He JD, Lu XJ. CRISPR-Cas9 for medical genetic screens: applications and future perspectives. J Med Genet. 2016;53(2):91\u20137.","journal-title":"J Med Genet"},{"issue":"2","key":"839_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.scr.2016.09.008","volume":"17","author":"AM Bara","year":"2016","unstructured":"Bara AM, Messana A, Herring A, Hazelbaker DZ, Eggan K, Barrett LE. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):441\u20133.","journal-title":"Stem Cell Res"},{"issue":"11","key":"839_CR7","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1038\/mtna.2016.92","volume":"5","author":"MC Latella","year":"2016","unstructured":"Latella MC, Di Salvo MT, Cocchiarella F, Benati D, Grisendi G, Comitato A, et al. In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina. Mol Ther Nucleic Acids. 2016;5(11):e389.","journal-title":"Mol Ther Nucleic Acids"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"35766","DOI":"10.1038\/srep35766","volume":"6","author":"L Enkler","year":"2016","unstructured":"Enkler L, Richer D, Marchand AL, Ferrandon D, Jossinet F. Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system. Sci Rep. 2016;6:35766.","journal-title":"Sci Rep"},{"issue":"11","key":"839_CR9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik RJ, Mimee M, Lu TK. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014;32(11):1141\u20135.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"839_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"5858","key":"839_CR11","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320.","journal-title":"Science"},{"issue":"16","key":"839_CR12","doi-asserted-by":"publisher","first-page":"9000","DOI":"10.1128\/JVI.77.16.9000-9007.2003","volume":"77","author":"T Ogata","year":"2003","unstructured":"Ogata T, Kozuka T, Kanda T. Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA. J Virol. 2003;77(16):9000\u20137.","journal-title":"J Virol"},{"issue":"9","key":"839_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nbt.1562","volume":"27","author":"D Hockemeyer","year":"2009","unstructured":"Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009;27(9):851\u20137.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"839_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.1674","volume":"8","author":"A Lombardo","year":"2011","unstructured":"Lombardo A, Cesana D, Genovese P, Di Stefano B, Provasi E, Colombo DF, et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods. 2011;8(10):861\u20139.","journal-title":"Nat Methods"},{"issue":"8","key":"839_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1101\/gr.106773.110","volume":"20","author":"RC DeKelver","year":"2010","unstructured":"DeKelver RC, Choi VM, Moehle EA, Paschon DE, Hockemeyer D, Meijsing SH, et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res. 2010;20(8):1133\u201342.","journal-title":"Genome Res"},{"issue":"5","key":"839_CR16","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/stem.1653","volume":"32","author":"K Qian","year":"2014","unstructured":"Qian K, Huang CT, Chen H, Blackbourn LW, Chen Y, Cao J, et al. A simple and efficient system for regulating gene expression in human pluripotent stem cells and derivatives. Stem Cells. 2014;32(5):1230\u20138.","journal-title":"Stem Cells"},{"issue":"5","key":"839_CR17","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1093\/nar\/gks1446","volume":"41","author":"M Holkers","year":"2013","unstructured":"Holkers M, Maggio I, Liu J, Janssen JM, Miselli F, Mussolino C, et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res. 2013;41(5):e63.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"839_CR18","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1093\/nar\/gku305","volume":"42","author":"C Mussolino","year":"2014","unstructured":"Mussolino C, Alzubi J, Fine EJ, Morbitzer R, Cradick TJ, Lahaye T, et al. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res. 2014;42(10):6762\u201373.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"839_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.5966\/sctm.2013-0212","volume":"3","author":"Y Luo","year":"2014","unstructured":"Luo Y, Liu C, Cerbini T, San H, Lin Y, Chen G, et al. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases. Stem Cells Transl Med. 2014;3(7):821\u201335.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"839_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.stem.2014.06.011","volume":"15","author":"C Smith","year":"2014","unstructured":"Smith C, Gore A, Yan W, Abalde-Atristain L, Li Z, He C, et al. Whole-genome sequencing analysis reveals high specificity of CRISPR\/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell. 2014;15(1):12\u20133.","journal-title":"Cell Stem Cell"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ymeth.2015.12.012","volume":"101","author":"F Oceguera-Yanez","year":"2016","unstructured":"Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, et al. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods. 2016;101:43\u201355.","journal-title":"Methods"},{"key":"839_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/7651_2014_139","volume":"1357","author":"RJ Su","year":"2016","unstructured":"Su RJ, Neises A, Zhang XB. Generation of iPS cells from human peripheral blood mononuclear cells using episomal vectors. Methods Mol Biol. 2016;1357:57\u201369.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"839_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.23354","volume":"51","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010;51(1):297\u2013305.","journal-title":"Hepatology"},{"issue":"1","key":"839_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.stem.2014.04.020","volume":"15","author":"A Veres","year":"2014","unstructured":"Veres A, Gosis BS, Ding Q, Collins R, Ragavendran A, Brand H, et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell. 2014;15(1):27\u201330.","journal-title":"Cell Stem Cell"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-med-050311-163324","volume":"64","author":"AB Cherry","year":"2013","unstructured":"Cherry AB, Daley GQ. Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med. 2013;64:277\u201390.","journal-title":"Annu Rev Med"},{"issue":"3","key":"839_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrm.2016.10","volume":"17","author":"A Trounson","year":"2016","unstructured":"Trounson A, DeWitt ND. Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol. 2016;17(3):194\u2013200.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"839_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lfs.2014.05.004","volume":"108","author":"B Jia","year":"2014","unstructured":"Jia B, Chen S, Zhao Z, Liu P, Cai J, Qin D, et al. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells. Life Sci. 2014;108(1):22\u20139.","journal-title":"Life Sci"},{"issue":"1","key":"839_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bbrc.2016.02.083","volume":"472","author":"J Pang","year":"2016","unstructured":"Pang J, Wu Y, Li Z, Hu Z, Wang X, Hu X, et al. Targeting of the human F8 at the multicopy rDNA locus in hemophilia A patient-derived iPSCs using TALENickases. Biochem Biophys Res Commun. 2016;472(1):144\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"839_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","volume":"17","author":"CY Park","year":"2015","unstructured":"Park CY, Kim DH, Son JS, Sung JJ, Lee J, Bae S, et al. Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9. Cell Stem Cell. 2015;17(2):213\u201320.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"839_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.stem.2010.06.002","volume":"7","author":"J Staerk","year":"2010","unstructured":"Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell. 2010;7(1):20\u20134.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"839_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.gpb.2013.09.001","volume":"11","author":"XB Zhang","year":"2013","unstructured":"Zhang XB. Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics. 2013;11(5):264\u201374.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"3","key":"839_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/cr.2011.12","volume":"21","author":"BK Chou","year":"2011","unstructured":"Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011;21(3):518\u201329.","journal-title":"Cell Res"},{"issue":"1","key":"839_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2012.02.086","volume":"516","author":"BA DeRosa","year":"2012","unstructured":"DeRosa BA, Van Baaren JM, Dubey GK, Lee JM, Cuccaro ML, Vance JM, et al. Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells. Neurosci Lett. 2012;516(1):9\u201314.","journal-title":"Neurosci Lett"},{"issue":"3","key":"839_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013;31(3):458\u201366.","journal-title":"Stem Cells"},{"issue":"9","key":"839_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/scd.2014.0347","volume":"24","author":"B Song","year":"2015","unstructured":"Song B, Fan Y, He W, Zhu D, Niu X, Wang D, et al. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR\/Cas9 system. Stem Cells Dev. 2015;24(9):1053\u201365.","journal-title":"Stem Cells Dev"},{"issue":"9","key":"839_CR36","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1101\/gr.173427.114","volume":"24","author":"F Xie","year":"2014","unstructured":"Xie F, Ye L, Chang JC, Beyer AI, Wang J, Muench MO, et al. Seamless gene correction of beta-thalassemia mutations in patient-specific iPSCs using CRISPR\/Cas9 and piggyBac. Genome Res. 2014;24(9):1526\u201333.","journal-title":"Genome Res"},{"issue":"6","key":"839_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","volume":"13","author":"G Schwank","year":"2013","unstructured":"Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, Demircan T, et al. Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell. 2013;13(6):653\u20138.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"839_CR38","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/stem.1969","volume":"33","author":"X Huang","year":"2015","unstructured":"Huang X, Wang Y, Yan W, Smith C, Ye Z, Wang J, et al. Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation. Stem Cells. 2015;33(5):1470\u20139.","journal-title":"Stem Cells"},{"issue":"11","key":"839_CR39","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/nprot.2016.129","volume":"11","author":"CY Park","year":"2016","unstructured":"Park CY, Sung JJ, Choi SH, Lee DR, Park IH, Kim DW. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR\/Cas9. Nat Protoc. 2016;11(11):2154\u201369.","journal-title":"Nat Protoc"},{"issue":"5","key":"839_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.15252\/emmm.201506039","volume":"8","author":"Y Guan","year":"2016","unstructured":"Guan Y, Ma Y, Li Q, Sun Z, Ma L, Wu L, et al. CRISPR\/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse. EMBO Mol Med. 2016;8(5):477\u201388.","journal-title":"EMBO Mol Med"},{"issue":"6166","key":"839_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014;343(6166):80\u20134.","journal-title":"Science"},{"issue":"5","key":"839_CR42","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1111\/hae.12924","volume":"22","author":"C Lyu","year":"2016","unstructured":"Lyu C, Xue F, Liu X, Liu W, Fu R, Sun T, et al. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing. Haemophilia. 2016;22(5):e427\u201334.","journal-title":"Haemophilia"},{"key":"839_CR43","doi-asserted-by":"publisher","first-page":"28566","DOI":"10.1038\/srep28566","volume":"6","author":"JP Zhang","year":"2016","unstructured":"Zhang JP, Li XL, Neises A, Chen W, Hu LP, Ji GZ, et al. Different effects of sgRNA length on CRISPR-mediated gene knockout efficiency. Sci Rep. 2016;6:28566.","journal-title":"Sci Rep"},{"issue":"9","key":"839_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31(9):822\u20136.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"839_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","volume":"31","author":"V Pattanayak","year":"2013","unstructured":"Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013;31(9):839\u201343.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"839_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nbt.2916","volume":"32","author":"C Kuscu","year":"2014","unstructured":"Kuscu C, Arslan S, Singh R, Thorpe J, Adli M. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat Biotechnol. 2014;32(7):677\u201383.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"839_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31(9):827\u201332.","journal-title":"Nat Biotechnol"},{"key":"839_CR48","doi-asserted-by":"crossref","first-page":"e04766","DOI":"10.7554\/eLife.04766","volume":"3","author":"S Lin","year":"2014","unstructured":"Lin S, Staahl BT, Alla RK, Doudna JA. Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. elife. 2014;3:e04766.","journal-title":"elife"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-0839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-0839-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-0839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T19:20:37Z","timestamp":1554492037000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-0839-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-0839-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LZ is a member of the hemostasis and thrombosis group of Chinese Medical Association Hematology and a Chinese editorial board of Haemophilia, an official journal of the World Federation of hemophilia. For many years he engaged in the research of hemophilia, idiopathic thrombocytopenic purpura (ITP), and essential thrombocythemia (ET), including clinical work and basis study. He is also involved in a variety of stem cell research, including stem cell engineering, industrial platform construction, the establishment of stem cell separation, efficient amplification, frozen storage and recovery, and large-scale production of cellular products.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The study was approved by the Ethics Committee of the Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, informed consent was obtained from the participant and his legal guardians, and ethics approval for NOD\/SCID mice was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant and his legal guardians declare their support for the publication and its contents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"92"}}